Pharmaxis Ltd (PXS)

 NULL
   
  • 52 Week High: NULL
  • 52 Week Low: $0.00
  • Currency: Australian Dollars
  • Shares Issued: 394.32m

Pharmaxis Ltd Overview

Pharmaxis is a specialist pharmaceutical company engaged in research, development and commercialisation of new therapies for chronic respiratory diseases and auto immune diseases. Its patented products include Bronchitol and Aridol. Pharmaxis is headquartered in Sydney, Australia with additional offices in the US, UK and China.

3 Month Chart

3 Month Chart

1 Year Chart

1 Year Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0%
Div Cover n/a
Op Mrgn -5963.2%
ROCE n/a
Latest F'cast
P/E n/a
PEG n/a
Pr/Revenue n/a
Pr/Book n/a
Latest F'cast
Revenue 39.2%
PBT n/a
EPS n/a
DPS n/a

Pharmaxis Ltd Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-06 0.01 (17.73) (10.57)¢ n/a n/a n/a n/a 0.0%
30-Jun-07 0.20 (24.16) (12.95)¢ n/a n/a n/a n/a 0.0%
30-Jun-08 0.53 (20.41) (10.28)¢ n/a n/a n/a n/a 0.0%
30-Jun-09 0.60 (35.12) (17.13)¢ n/a n/a n/a n/a 0.0%
30-Jun-10 0.83 (46.29) (19.99)¢ n/a n/a n/a n/a 0.0%

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: Forecast figures based on normalised accounts.

 

Pharmaxis Ltd Market Data

Currency Australian Dollars
% Change 0.00 %
52 Week High NULL
52 Week Low $0.00
Shares Issued 394.32m

Top of Page